Comparison of the novel CompEx asthma exacerbation endpoint to the ATS/ERS adapted moderate/severe asthma exacerbation definition used in the MITRA trial.

Göran Eriksson,Hendrik Nolte,Christian Ljørring,Bente Riis,Johann Christian Virchow

Respiratory Medicine（2019）

引用 0|浏览13

暂无评分

摘要

•CompEx may be a valuable tool for assessing asthma exacerbations in clinical trials.•CompEx and the moderate/severe exacerbation endpoint generated similar results.•Results with CompEx mimicked those originally obtained during the MITRA trial.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要